SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Ranbaxy Labs
Ranbaxy Labs
BSE: 500359NSE: RANBAXYISIN: INE015A01028

25th-Feb-2013 11:53Source: BSE

Ranbaxy Labs - Update on Atorvastatin Recall

In Nov 2012, Ranbaxy Pharmaceuticals Inc., the US subsidiary of Ranbaxy, had initiated a voluntary recall for select batches and strengths of Atorvastatin calcium tablets only in the USA. However, Ranbaxy continues to supply this product in other markets across the world.

More Announcements on:

15th-Dec-2014 13:21Source: NSE

Ranbaxy Laboratories Limited

9th-Dec-2014 15:37Source: NSE

Ranbaxy Laboratories Limited

8th-Dec-2014 14:46Source: NSE

Ranbaxy Laboratories Limited

8th-Dec-2014 09:46Source: NSE

Ranbaxy Laboratories Limited

8th-Dec-2014 09:26Source: BSE

Ranbaxy Labs - Statement

5th-Dec-2014 14:22Source: NSE

Ranbaxy Laboratories Limited

4th-Dec-2014 13:08Source: NSE

Ranbaxy Laboratories Limited

1 2 3 4 5 Next >>
OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(December 18, 2014)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
2400

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1429

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1429

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.